SMITH, MOORE & CO. – Eli Lilly and Company Transaction History
SMITH, MOORE & CO. portfolio value:
$1.72M
portfolio value
SMITH, MOORE & CO. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.01% | -223 shares | -77K | $323.35 | 5.33K |
| Q2 2022 | share | Decrease | -12.60% | -801 shares | -19K | $324.23 | 5.55K |
| Q1 2022 | share | Increase | +0.81% | 51 shares | 78K | $286.37 | 6.35K |
| Q4 2021 | share | Increase | +5.71% | 341 shares | 364K | $277.25 | 6.30K |
| Q3 2021 | share | Increase | +3.97% | 228 shares | 62K | $230.3 | 5.96K |
| Q2 2021 | share | Decrease | -0.35% | -20 shares | 241K | $228.04 | 5.73K |
| Q1 2021 | share | Increase | +3.41% | 190 shares | 136K | $184.81 | 5.75K |
| Q4 2020 | share | Decrease | -9.74% | -601 shares | 27K | $166.32 | 5.56K |
| Q3 2020 | share | Increase | +9.57% | 539 shares | -12K | $145.05 | 6.17K |
| Q2 2020 | share | Increase | +18.45% | 877 shares | 266K | $160.1 | 5.63K |
| Q1 2020 | share | Increase | +3.48% | 160 shares | 55K | $134.64 | 4.75K |
| Q4 2019 | share | Increase | +35.64% | 1.20K shares | 225K | $126.91 | 4.59K |
| Q3 2019 | share | Decrease | -0.65% | -22 shares | 1K | $107.36 | 3.38K |
| Q2 2019 | share | Increase | +37.13% | 923 shares | 55K | $105.74 | 3.40K |
| Q1 2019 | share | Decrease | -2.16% | -55 shares | 29K | $123.17 | 2.48K |
| Q4 2018 | share | Decrease | -0.08% | -2 shares | 21K | $109.26 | 2.54K |
| Q3 2018 | share | Increase | +4.14% | 101 shares | 65K | $100.8 | 2.54K |
| Q2 2018 | share | Increase | 0.00% | 2.44K shares | 208K | $79.72 | 2.44K |
| Q1 2018 | share | Decrease | -100.00% | -2.39K shares | -202K | $71.78 | 0 |
| Q4 2017 | share | Increase | +0.04% | 1 shares | -3K | $77.79 | 2.39K |
| Q3 2017 | share | Increase | 0.00% | 2.39K shares | 205K | $78.29 | 2.39K |